Jobs / United States / Sanofi US Services INC
Thought Leader Liaison Gastroenterology Midwest
Sanofi US Services INC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Sanofi US Services INC paid sponsored hires in similar roles3 certified filings for “Associate Statistical Project Leader” (Statisticians) in NJ: $113k–$122k, median $122k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Sanofi US Services INC
The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →
About the role
Job Title: R2872676 Thought Leader Liaison Gastroenterology Midwest Location: Midwest Territory (Michigan, Ohio, Indiana, Illinois) About the Job: Sanofi, a global and diversified healthcare leader, discovers, develops, and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with eight growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, rare blood disorders, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi is dedicated to making a major positive impact on the lives of people with serious diseases. Summary : Sanofi's Gastroenterology Thought Leader Liaison Team is expected to possess a high level of clinical and customer knowledge, have experience with both field and headquarters protocols and procedures, and possess drive and spirit to engage and influence KOLs to help build educational platforms and inform the execution of current and future brand and disease-state strategies in three core areas: Market Insights, KOL Engagement, and Commercial HCP Speaker Bureau. The Dupixent franchise is a patient centric organization responsible for delivering the highest quality education and service regarding disease and treatment. The goal of the franchise is to penetrate existing and new markets to meet business goals by educating physicians and healthcare professionals on Dupixent’s approved indications while upholding the Company's mission and values. The EOE Thought Leader Liaison, Dupilumab role is a field-based, national marketing role working closely with gastroenterology U.S Key Opinion Leaders (KOLs) and cross-functional partners. The Gastroenterology TLL will work closely with other field professionals including but not limited to National Sales Directors, Zone Business Directors, Regional Business Directors, Area Business Managers, Marketing, Medical Affairs, Sales, and Market Access. The behaviors that are critical for success are ability to plan and execute long-term strategy cross-functionally through collaboration, communication, and relationship building. The Gastroenterology TLL will report directly to the Head, Respiratory Thought Leader Liaisons. All TLL interactions are always within label, and consistent with commercial compliance, legal and regulatory guidelines. Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you'll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. About Sanofi: We're an R&D-driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people's lives. Main Responsibilities: • Work on problems of diverse scope where analysis of situations or data requires an in-depth evaluation of variable factors. • Play a key role in enhancing the understanding of GI diseases and the role of dupilumab in the management of those diseases using on label materials. • Effectively partner with alliance partner, Regeneron, to develop and execute GI KOL national strategy. • Effectively manage the GI TLL budget against key brand priorities • Assemble and lead cross-functional teams toward a shared vision of success. • Aligning with cross functional account plans and teams, the Gastroenterology TLL orchestrates resources with the top 10%-15% of identified KOLs. • Responsible for execution of regional insig